Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Louis-Philippe Boulet, MD
CONTACT
Julie Turmel, PhD
CONTACT
Lead
Louis-Philippe Boulet
With
Subjects will receive benralizumab every 4 weeks for three doses followed by a fourth dose 8 weeks later. On baseline and after 4, 16 and 20 weeks, subjects will be assess for airway responsiveness to exercise and exercise tolerance.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted